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We studied the single nucleotid polymorphisms (SNP) distribution of -174 G/C interleukin-6 gene (IL-6) and determined 
its associations with functional outcomes after non-lacunar stroke in 33 patients with normal body weight and in 37 pa-
tients with abdominal obesity (AO) II class. The study has involved patients of similar age (56 to 65 years), with the 
similar clinical disease severity on admission (5-10 points according to NIHS scale), with relatively similar cerebral lesion 
volumes (from 10 to 20 cm3), without diabetes mellitus and severe co-morbidity. Abdominally obese patients II class 
with non-lacunar strokes have significantly more common 174 C allele of the IL-6 gene compared with patients with 
normal body weight (65% versus 45%, p<0,05). In patients with normal body weight G/G genotype of -174 G/C gene 
IL-6 was significantly associated with more severe acute stroke an increased rate of late "disabling" functional states 
(values of modified Rankin scale more then 2 points) in 12 weeks after stroke. AO II class hasn’t any patterns of clinical 
and functional outcomes distribution depending on SNP -174 G/C gene IL-6. 
Key words: ischemic non-lacunar stroke, abdominal obesity, interleukin-6, gene, -174 G/C single nucleotide polymor-
phism. 
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Introduction 
In recent years in scientific literature has emerged a 
lot of scientific reports which prove independent and sig-
nificant influences of obesity on acute ischemic strokes 
and functional outcome. In particular, in previous works 
we demonstrated that obese patients (especially with ab-
dominal obesity) had a more severe strokes, more fre-
quent development of various post-stroke complications 
and, consequently, longer hospital stay and worse func-
tional outcome [1]. 
Among the key factors that may determine the clinical 
severity of stroke, great importance has the intensity of 
local and systemic post-ischemic inflammatory response. 
Proinflammatory cytokine - interleukin-6 (IL-6) is one of 
the key regulators of post-ischemic inflammatory re-
sponse intensity through the influence on the synthesis 
and secretion of acute-phase proteins, chemokines, ad-
hesion molecules, etc. High serum IL-6 level in the first 
days after ischemic stroke onset is associated with the 
progression of secondary post-ischemic cerebral injury 
and is an independent predictor of acute stroke severity 
as well as early neurological complications and long-term 
functional outcome [10]. 
The degree of IL-6 blood elevation at acute stroke is 
closely correlated with the cerebral lesion volumes [10]. 
However, we had defined (the article in press), that under 
conditions of similar cerebral lesions volumes, abdomi-
nally obese patients (I-II obesity class) have significantly 
increased IL-6 blood levels at 1st as well as at 10th day 
after stroke onset compared with normal weight patients. 
But the source of a significant IL-6 serum in abdomi-
nally obese patients under conditions of acute ischemic 
stroke still remains unknown. 
Leptin deficient obese mice, compared with wild-type 
ones, have significantly elevated serum IL-6 after ex-
perimental ischemic stroke. Because brain tissue level of 
IL-6 was decreased in post-ischemic obese mice com-
pared with wild-type animals, authors suggested that in 
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acute stroke just adipose tissue is a major source of se-
rum IL-6 [11].  
In recent years, a number of investigations had 
shown that the degree of increase in IL-6 concentration in 
patients with ischemic stroke is largely determined by 
genetic factors. Expression of IL-6 is mainly regulated at 
the transcriptional level, gene promoter of IL-6 comprises 
several single nucleotide polymorphisms (SNP), which 
significantly affects the gene transcription. SNP in the 
promoter region of IL-6 gene as substitution of cytosine 
to guanine at position 174 (-174 G/C) is associated with 
changes in IL-6 blood concentration. There are conflicting 
scientific data about these associations with ischemic 
stroke, as well as about associations between genotype -
174 G/C and clinical and functional features of ischemic 
stroke [3, 12]. Inconsistency of above mentioned results 
may reflect the regulatory processes’ complexity in post-
stroke inflammatory response, diversity of IL-6 physiol-
ogy, may be a consequence of heterogeneity of the stud-
ied patients groups, as well as ischemic strokes, etc. 
Perhaps, the -174 G/C SNP of the IL-6 gene is one of the 
factors that could determine more severe non-lacunar 
strokes and more intensive post-ischemic inflammatory 
response in abdominally obese patients. 
Purpose of the study was to indentify the distribution 
of -174 G/C SNP of the IL-6 gene and to determine asso-
ciations between this SNP and clinical features, as well 
as functional outcomes of non-lacunar strokes in patients 
of different weight categories. 
Materials and methods 
In the study we have recruited 70 subjects of both gen-
ders (33 patients with normal body weight and 37 patients 
with class 2 abdominal obesity) with acute ischemic non-
lacunar (atherothrombotic and cardioembolic subtypes) 
hemispheric strokes. All patients were admitted to Poltava 
city hospital not later than 24 hours after stroke onset. 
Non-lacunar stroke subtype was verified by neuro-
visualization. 
Peculiarities of acute ischemic stroke and post-stroke 
functional outcome are determined by numerous factors, 
among which the most important are the patient's age, 
stroke severity at admission (according to National Insti-
tutes of Health Stroke Scale (NIHSS)), the size of the 
cerebral lesion, previous strokes, and co-morbidities [14]. 
Therefore, to unify above mentioned conditions we had 
selected patients with relatively similar age (from 56 to 65 
years), similar disease’s severity at admission (from 5 to 
10 points according to NIHSS), similar cerebral lesion 
size (from 10 to 20 cm3). Patients didn’t have diabetes 
mellitus and severe co-morbidities that could influence of 
neurological and functional recovery (oncological dis-
eases, convulsive syndrome, hematological diseases, 
cardiac, liver, kidney and respiratory insufficiencies, pro-
gressive angina pectoris, acute myocardial infarction, 
vascular dementia, alcoholism, etc). Moreover, patients 
didn’t have acute neurological episodes (according to 
medical records) and didn’t have neuroimaging signs of 
previously unrecognized non-lacunar strokes. 
Cerebral lesion volume was estimated by calculating 
the approximate volume of an ellipsoid on computed to-
mography brain scans or T-2 weighted magnetic reso-
nance imaging brain scans. 
Patient's body weight was determined with mechani-
cal weights during hospitalization. In severe cases, body 
weight was measured after patient improvement, or ac-
cording to patient’s relatives. Body mass index (BMI) was 
calculated as weight in kilograms divided by the square 
of height in meters. Body weight categories were formed 
on the basis of BMI: normal body weight - BMI 20.0-24.9 
kg/m2, obesity class II – BMI >35.0 kg/m2. Waist-to-hip 
ratio (WHR) was calculated as a measure of abdominal 
obesity. Waist circumference was measured with a soft 
tape midway between the lowest rib and the iliac crest. 
Hip circumference was measured over the widest part of 
the gluteal region. According to World Health Organiza-
tion criteria, WHR >0.9 in men and >0.85 in women were 
denoted abdominal obesity. 
In hospital stroke patients received uniform therapy 
(antiplatelet drugs for atherothrombotic stroke, anticoagu-
lant drugs for cardioembolic stroke, hypotensive, meta-
bolic, nootropic drugs, etc), physiotherapy, and massage. 
After hospital discharge patients took antihypertensive, 
antiplatelet drugs and continued outpatient rehabilitation 
services (physiotherapy, speech therapyy, etc.). 
The cpicture of stroke linical has been analyzed by 
NIHSS score at the 10th day of hospital stay. Post-stroke 
functional outcomes were evaluated by modified Rankin 
scale (mRS). We had dichotomized functional outcome: 
favorable – mRS ≤2 (patient able to look after own affairs 
without assistance) versus unfavorable – mRS>2 (patient 
requires assistance in daily life. 
Molecular genetic analysis was performed in a labora-
tory «Gentrees LTD» (Poltava). DNA was extracted from 
white blood cells using ion exchange resin Chelex-100 
[13]. Determination of allelic status of-174 G/C SNP of 
the IL-6 gene (rs1800795) was performed as it had been 
described by Spanish scientists [4]. Polymerase chain 
reaction (PCR) was performed in the thermocycler Tertsik 
(DNA-Technology, Russia).  
To amplify the fragment of IL-6 gene, which  
contains the polymorphic site 174 G/C, oligonucleotide 
have been used primers – direct IL6174F: 
TGACTTCAGCTTTACTCTTTGT and reverse IL6174R: 
AATAGGTTTTGAGGGCCATG. Restriction of the ampli-
fication products was performed using endoculease LweI 
(SfaNI) (MBI Fermentas, Lithuania). Restriction materials 
were analyzed by electrophoresis in 2% agarose gel in 
1хТВЕ. As molecular weight marker it had been used 
DNA pUC19, which was hydrolysed by endonuclease 
MspI (MBI Fermentas, Lithuania). Visualization of amplifi-
cation and restriction products was performed by gel dye-
ing with ethidium bromide and photographing in ultravio-
let light transilluminator. 
Statistical processing of the results was performed by 
means of software package Statistika Excel. Distributions 
of allele frequencies in different weight body groups, 
equality of the actual distribution of genotypes, as well as 
the actual and theoretical ones (according to Hardy-
Weinberg equilibrium) were analyzed using the criterion 
χ2. Comparison of functional outcomes rates depending 
on the genotype was calculated using Fisher's exact test. 
Quantitative data (NIHSS score) is shown as mean (M), 
standard error of mean (m). Data from patients were ana-
lyzed using the Mann-Whitney U test for the comparison 
of continuous variables. P-value less 0.05 was taken to 
indicate statistical significance. 
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Fig. 1. Electrophoretogram of PCR products genotyped by SNP -174 G/C IL-6 gene: M - molecular weight marker DNA pUC19, 
hydrolyzed by endonuclease MspI.; 1-9 - DNA of patients with non-lacunar stroke and different genotypes. 
Restriction fragment of 164 nucleotides pairs matches 
174 C allele, the two restriction fragments of 112 and 52 
nucleotides pairs matches 174 G allele of the IL-6 gene. 
Table 1 
Allele frequencies of SNP -174 G/C of the IL-6 gene in patients of different weight categories with non-lacunar stroke 
Genotype Patients group Totally 
G/G G/С С/С 
Allele frequencies Statistics 
normal body weight 33 13 10 10 pG=0,55; рС=0,45 





n – the number of patients; pG и рС –frequencies of G-allele and С-allele; χ2 и χ2st – actual and threshold criterion value; 
df – the number of steps of freedom; р – significance level. 
 
The table 1 shows, in normal weight patients with 
non-lacunar stroke G-allele is major allele, but in ab-
dominally obese patients major allele is C-allele; and this 
difference has statistical significance. In literature there 
are contradictory data about relations between -174 G/C 
SNP of the IL-6 gene and risk of stroke. In mixed popula-
tion of US patients with cardiovascular and cerebrovas-
cular pathology, presence of the −174C allele was asso-
ciated with risk of «silent» MRI infarcts (odds ratio 1.5) 
[7]. Among Italian patients with stroke history, 174 G al-
lele was major (66.5%), whereas in the control group the 
frequency of this allele was only 47.3% [5]. According to 
Austrian researchers, there are no links between-174 
G/C SNP of the IL-6 gene and risk of ischemic stroke [6]. 
The significant increase of allele 174 C frequency in a 
abdominally obese patients may be a manifestation of its 
selectivity towards stroke risk, and maybe (that is more 
likely) a manifestation of the general population patterns 
– C-allele is associated with obesity. In particular, in 
French and Swedish populations 174 C allele of IL-6 
gene was significantly more common in overweight and 
obese people [15].  
Table 2 
Ratio of -174 G/C IL-6 genotypes in patients of different weight categories with non-lacunar stroke 
Patients group G/G G/С С/С 
 n % n % n % 
Statistics 
normal body weight 11 39,4 10 30,3 10 30,3 





n – the number of patients; χ2 и χ2st – actual and threshold criterion value; df – the number of steps of freedom; р – sig-
nificance level. 
 
Table 2 shows the significant increase of C/C homo-
zygotes and heterozygotes frequency and, thus reducing 
the proportion of G/G homozygote among abdominally 
obese patients with non-lacunar strokes in comparison 
with normal weight patients. In the analysis of this phe-
nomenon it is necessary to take into account the peculi-
arities -174 G/C SNP of the IL-6 gene in obese humans. 
In particular, C/C genotype had significantly associations 
with abdominal obesity in French and German popula-
tions [2, 8]. According to Swedish scientists, there were 
significant odds ratios for the association of CC (2.13) 
and GC (1.76) genotypes with overweight (BMI>25 
kg/m2) in healthy humans [15]. Genetically determined 
individual differences in production of IL-6 may be rele-
vant for the regulation of body fat mass. Based on these 
observations, the authors concluded that genetically de-
termined individual differences in production of IL-6 may 
be relevant for the regulation of body fat mass. 
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Table 3 
Structure of the population of patients with different weight and non-lacunar strokes according to -174 G/C SNP of the IL-6 gene 
Genotype, % Patients group The distribution of genotypes G/G G/C C/C 
Statistics 
actual 39,4 30,3 30,3 normal body weight 
theoretical 29,7 49,7 20,6 
χ2=15,31;  
p<0,05. 
actual 16,2 37,8 46,0 abdominal obesity 2 





% – percentages; χ2 и χ2st – фактическое и пороговое значения критерия; df – число степеней свободы; р – уро-
вень значимости. 
 
Table 3 shows that the distribution of genotypes in 
abdominally obese patients corresponds to the Hardy-
Weinberg equilibrium and doesn’t significantly deviate 
from it. Whereas in normal body weight patients distribu-
tion of genotypes is significantly deviates from this equi-
librium to a lack of heterozygotes. Perhaps, in the Ukrain-
ian population the heterozygous state of -174 G/C IL-6 
genes in normal body weight patients is a protective fac-
tor regarding the non-lacunar strokes. However, this as-
sumption needs to be further confirmed in a more exten-
sive group of patients. 
Table 4 
Dynamics of the NIHSS score at acute non-lacunar strokes in patients with different weight and -174 G/C SNP of the IL-6 gene 
Patients group Abdominal obesity 2 class Normal body weight 
Genotype G/G G/C C/C G/G G/C C/C 
1st  7,5±0,5 7,1±0,5 7,9±0,7 6,8±0,6 7,6±0,5 7,5±0,4 Day after stroke 
10th  5,5±0,6 5,5±0,4 5,4±0,3 4,9*±0,5 3,5±0,3 3,4±0,3 
* - significant difference in comparison with other genotypes carriers among normal body weight patients at 10th post-
stroke day (p <0,05). 
Table 4 shows that in patients with abdominal obesity 
2 class there is no difference in the clinical features of 
acute stroke, depending on the genotype. In normal body 
weight patients with -174 G/C SNP of the IL-6 gene there 
is a more severe clinical course of the disease. This fact 
is consistent with results of the Austrian study that 174 
G/G genotype carriers have a significantly worse NIHSS 
score on admission and at 1st week after stroke onset [6]. 
Although in the Indian population genotype 174 G/G, on 
the contrary, had been characterized by a significantly 
milder strokes at admission and more favorable course of 
the acute stroke [3], and authors had concluded that G/G 
genotype has protective effects against ischemic stroke 
[3] 
Table 5 
The rate of "disabling" states according to mRS after non-lacunar strokes depending on the weight categories and genotype of -174 G/C 
IL-6 gene 
The observation period at hospital discharge 12 weeks after stroke 
Patients group abdominal obesity 2 class  normal body weight 
abdominal obesity 2 
class  normal body weight 
mRS ≤2 >2 ≤2 >2 ≤2 >2 ≤2 >2 
G/G 1 5 3 10 2 4 3* 10* 
G/С 3 11 4 6 6 8 8 2 Genotype 
С/С 3 14 5 5 4 13 9 1 
* - significant difference in comparison with other genotypes carriers in normal body weight patients at 12 weeks after 
stroke (p <0,05). 
Table 5 shows that in normal body weight patients 
there is a certain structuring of functional consequences 
depending on the genotype: G/G homozygous state of -
174 G/C IL-6 gene was significantly associated with an 
increased incidence of "disabling" functional outcomes. A 
similar pattern was recorded by Austrian authors, carriers 
of 174 G/G genotype had significantly more often "poor" 
functional outcome (as mRS ≥ 4) at 3 months after stroke 
[6]. At the same time, in the Indian population, carriers of 
G/G genotype, by contrast, had «complete» recovery of 
functional ability (according mRS and index Barthel) at 3 
and 6 months after stroke [3]. 
Perhaps the lack of post-stroke functional recovery in 
normal-weight and -174 G/G homozygous patients are 
realized through the levels of IL-6 expression, and, pos-
sibly through other pathophysiological mechanisms which 
are associated with this genotype. The absence of any 
regularity between functional outcomes rate and geno-
type in abdominally obese patients may be explained, at 
least partially, by too little effects of -174 G/C SNP of the 
IL-6 gene on the clinical stroke features: lipotoxicity (for 
example, at the basal state, adipose tissue produces 
more than a third of the whole IL-6 amount in the body 
[9]) eliminates the modulating clinical effect of this SNP. 
Under conditions of abdominal obesity, proinflammatory 
factors associated with adipose tissue probably negate 
the effect of the genetic component. 
Conclusions 
1. Abdominally obese patients 2 class with non-
lacunar strokes have significantly more common 174 C 
allele of the IL-6 gene (increase of heterozygous and 
homozygous states) compared with patients with normal 
body weight.  
2. In patients with normal body weight G/G genotype 
of -174 G/C IL-6 gene was significantly associated with 
more severe acute stroke, and an increased rate of late 
"disabling" functional states (values of mRS more 2 
points) in 12 weeks after non-lacunar stroke.  
3. Abdominally obese patients 2 class do not have 
any patterns of clinical and functional outcomes distribu-
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tion after non-lacunar stroke depending on -174 G/C SNP 
of the IL-6 gene. 
References 
1. Litvinenko N.V. Klіnіko-neyrovіzualіzazіynі charakteristiki 
gostrogo perіodu nelakunarnich gemіsferal'nich іnsul'tіv u 
osіb z ozhirіnnyam / N.V. Litvinenko, M.Yu. Del'va, І.І. 
Del'va // Aktual'nі problemi suchasnoї medizini: Vіsnik 
Ukraїns'koї medichnoї stomatologіchnoї akademії. – 2011. 
– T. 11, № 4 (36), ch. 1. – S. 55-58. 
2. Berthier MT. The interleukin 6 −174G/C polymorphism is 
associated with indices of obesity in men / MT. Berthier, 
AM. Paradis, A. Tchernof [et al.] // Journal of Human Ge-
netics. – 2003. – V. 48 (1). – P. 14-19. 
3. Chakraborty B. Interleukin-6 gene -174 G/C promoter 
polymorphism predicts severity and outcome in acute 
ischemic stroke patients from north India / B. Chakraborty, 
D. Chowdhury, G. Vishnoi [et al.] // Journal of Stroke and 
Cerebrovascular Diseases. – 2012. – [Epub ahead of 
print]. 
4. Fernández-Real JM. Interleukin-6 gene polymorphism and 
lipid abnormalities in healthy subjects / JM. Fernández-
Real, M. Broch, J. Vendrell [et al.] // Journal of Clinical En-
docrinology & Metabolism. – 2000. – V. 85(3). – P.1334-
1339. 
5. Flex A. Proinflammatory genetic profiles in subjects with 
history of ischemic stroke / A. Flex, E. Gaetani, P. Papaleo 
[et al.] // Stroke. – 2004. – V. 35 (10). – P. 2270–2275. 
6. Greisenegger S. The (-174) G/C polymorphism in the in-
terleukin-6 gene is associated with the severity of acute 
cerebrovascular events / S. Greisenegger, G. Endler, D. 
Haering [et al.] // Thrombosis Research. – 2003. – N. 110. 
– P. 181–186. 
7. Jenny NS. In the elderly, interleukin-6 plasma levels and 
the -174G/C polymorphism are associated with the devel-
opment of cardiovascular disease / NS. Jenny, RP. Tracy, 
MS. Ogg [et al.] // Arteriosclerosis, Thrombosis, and Vas-
cular Biology. – 2002. – N. 22. – 2066–2071. 
8. Klipstein-Grobusch K. Interleukin-6 g.-174G>C promoter 
polymorphism is associated with obesity in the EPIC-
Potsdam Study / K. Klipstein-Grobusch, M. Mohlig, J. 
Spranger [et al.] // Obesity. – 2006. –N. 14. – P. 14-18. 
9. Mohamed-Ali V. Subcutaneous adipose tissue releases 
interleukin-6, but not tumor necrosis factor-alpha, in vivo / 
V. Mohamed-Ali, S. Goodrick, A. Rawesh [et al.] // The 
Journal of Clinical Endocrinology & Metabolism. – 1997. – 
N. 82. – P. 4196–4200. 
10. Smith CJ. Peak plasma interleukin-6 and other peripheral 
markers of inflammation in the first week of ischemic 
stroke correlate with brain infarct volume, stroke severity 
and long-term outcome / CJ. Smith, HC. Emsley, CM. 
Gavin [et al.] // BMC Neurology. – 2004. – N. 4. – P. 2. 
11. Terao S. Inflammatory and injury responses to ischemic 
stroke in obese mice / S. Terao, K. Yilmaz, K. Stokes // 
Stroke. – 2008. – V. 39(3). – P. 943-950. 
12. Tso RA. Interleukin-6 174G/C Polymorphism and Ischemic 
Stroke: A Systematic Review / RA. Tso, JG. Merino, S. 
Warach // Stroke – 2007. – V. 38 (1). – P. 3070-3075. 
13. Walsh PS. Chelex 100 as a medium for extraction of DNA 
for PCR-based typing from forensic material / PS. Walsh, 
DA. Metzger, R. Higuchi // BioTechniques. – 1991.– N. 10. 
– P. 506-513. 
14. Weimar C. Predicting functional outcome and survival after 
acute ischemic stroke / C. Weimar, A. Ziegler, IR. Konig 
[et al.] // Journal of Neurology. – 2002. – V. 249 (7). – P. 
888-895. 
15. Wernstedt I. A common polymorphism in the interleukin-6 
gene promoter is associated with overweight / I. 
Wernstedt, AL. Eriksson, A. Berndtsson [et al.] // Interna-
tional Journal of Obesity and Related Metabolic Disorders. 
– 2004. – N. 28. – P. 1272–1279. 
 
Матеріал надійшов до редакції 29.04.2013 р. 
